Real-world study of tezepelumab for chronic nasal polyps
Part of Ear, nose & throat clinical trials.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years of age or older
- Diagnosed with nasal polyps (CRSwNP) for at least 12 months
- Been on nasal steroid sprays for at least 30 days
- Your doctor believes tezepelumab is appropriate for you
- Able to complete surveys via phone app or paper throughout the study
- Not in another clinical trial or study that could interfere with results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
This study collects information from people with chronic rhinosinusitis and nasal polyps in both nostrils. By tracking patients over time, researchers hope to learn more about the condition and how to improve care.
This study is testing a medicine called tezepelumab to see how it affects the lining (barrier) of the airways in people with severe asthma, with or without nasal polyps. Tezepelumab is given as an injection and may help reduce inflammation and improve asthma control.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This trial tests a new injectable medicine (lebrikizumab) for people with chronic sinusitis and nasal polyps that steroid treatments haven't controlled. It aims to reduce polyp size and improve breathing, smell, and congestion.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.